EWAS |
Entire 450K Array |
0.004 |
<0.001 |
0.06 |
< 0.001 |
Any Kegg |
Any CpG mapped to any gene in a KEGG pathway |
0.001 |
<0.001 |
0.066 |
0.075 |
Any Gene |
Any CpG mapped to any gene |
0.001 |
<0.001 |
0.065 |
0.082 |
hsa04950 |
Maturity onset diabetes of the young |
0.001 |
<0.001 |
0.014 |
0.054 |
hsa04640 |
Hematopoietic cell lineage |
<0.001 |
<0.001 |
0.023 |
0.023 |
hsa04614 |
Renin-angiotensin system |
<0.001 |
<0.001 |
0.024 |
0.002 |
hsa04514 |
Cell adhesion molecules (CAMs) |
<0.001 |
<0.001 |
0.028 |
0.036 |
hsa05412 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
<0.001 |
<0.001 |
0.027 |
0.029 |
hsa04612 |
Antigen processing and presentation |
<0.001 |
0.01 |
0.053 |
0.036 |
hsa04350 |
TGF-β signaling pathway |
<0.001 |
<0.001 |
0.039 |
0.005 |
hsa05410 |
Hypertrophic cardiomyopathy (HCM) |
<0.001 |
<0.001 |
0.04 |
0.023 |
hsa04020 |
Calcium signaling pathway |
<0.001 |
<0.001 |
0.042 |
0.012 |
hsa05414 |
Dilated cardiomyopathy |
<0.001 |
<0.001 |
0.05 |
0.024 |
hsa05218 |
Melanoma |
<0.001 |
0.002 |
0.053 |
0.283 |
hsa04320 |
Dorso-ventral axis formation |
<0.001 |
<0.001 |
0.036 |
0.02 |
hsa04920 |
Adipocytokine signaling pathway |
<0.001 |
<0.001 |
0.05 |
0.026 |
hsa05200 |
Pathways in cancer |
<0.001 |
<0.001 |
0.054 |
0.097 |
hsa04512 |
ECM-receptor interaction |
<0.001 |
<0.001 |
0.077 |
0.007 |
hsa04670 |
Leukocyte transendothelial migration |
<0.001 |
<0.001 |
0.054 |
0.013 |
hsa04810 |
Regulation of actin cytoskeleton |
<0.001 |
<0.001 |
0.063 |
0.038 |
hsa04914 |
Progesterone-mediated oocyte maturation |
0.001 |
0.001 |
0.054 |
0.039 |
hsa04650 |
Natural killer cell mediated cytotoxicity |
<0.001 |
<0.001 |
0.060 |
0.005 |
hsa03320 |
PPAR signaling pathway |
<0.001 |
<0.001 |
0.057 |
0.026 |
hsa04150 |
mTOR signaling pathway |
0.001 |
0.003 |
0.062 |
0.004 |
hsa04510 |
Focal adhesion |
<0.001 |
<0.001 |
0.083 |
0.016 |
hsa04520 |
Adherens junction |
0.001 |
<0.001 |
0.051 |
0.135 |
hsa04330 |
Notch signaling pathway |
<0.001 |
0.002 |
0.07 |
0.048 |